`Patent No. 9,220,698
`Patent Owners’ Mandatory Notices
`
`
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`______________
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`______________
`
`DR. REDDY’S LABORATORIES INC.
`Petitioner
`
`v.
`
`POZEN INC. and HORIZON PHARMA USA, INC.
`Patent Owners
`______________
`
`Case No. IPR2018-00894
`Patent No. 9,220,698
`______________
`
`PATENT OWNERS’ MANDATORY NOTICES
`37 C.F.R. § 42.8
`
`
`
`
`Case No. IPR2018-00894
`Patent No. 9,220,698
`Patent Owners’ Mandatory Notices
`
`
`Pursuant to 37 C.F.R. § 42.8, the real parties-in-interest for this proceeding
`
`hereby submit the following mandatory notices in response to the Petition for Inter
`
`Partes Review of U.S. Patent No. 9,220,698 (“the ’698 patent”), case number
`
`IPR2018-00894.
`
`
`
`REAL PARTY-IN-INTEREST (37 C.F.R. § 42.8(b)(1))
`
`The real parties-in-interest are:
`
`Pozen Inc., a corporation organized and existing under the laws of Delaware
`
`having its principal place of business at 8310 Bandford Way, Raleigh, NC 27615
`
`and at c/o Aralez Pharmaceuticals US Inc., 400 Alexander Park Drive, Princeton, NJ
`
`08540, which is wholly owned by;
`
`Aralez Pharmaceuticals Inc., a public corporation organized and existing
`
`under the laws of British Columbia having its principal place of business at 7100
`
`West Credit Avenue, Suite 101, Mississauga, Ontario L5N 0E4;
`
`Horizon Pharma USA, Inc., a corporation organized and existing under the
`
`laws of the State of Delaware having its principal place of business at 150 S.
`
`Saunders Road, Lake Forest, Illinois, 60045, which is wholly owned by;
`
`Horizon Pharma, Inc., a corporation organized and existing under the laws of
`
`the State of Delaware having its principal place of business at 150 S. Saunders Road,
`
`Lake Forest, Illinois, 60045, which is wholly owned by;
`
`
`
`2
`
`
`
`Case No. IPR2018-00894
`Patent No. 9,220,698
`Patent Owners’ Mandatory Notices
`
`Horizon Pharma plc, a corporation organized and existing under the laws of
`
`Ireland, having its principal place of business at Connaught House, 1st Floor, 1
`
`Burlington Road, Dublin 4, Ireland.
`
`RELATED MATTERS 37 C.F.R. § 42.8(b)(2))
`
`
`Horizon Pharma, Inc. v. Mylan Pharmaceuticals Inc., 2:15-cv-03327
`
`(D.N.J.); Horizon Pharma, Inc. v. Mylan Pharmaceuticals Inc., 2:16-cv-04921
`
`(D.N.J); Horizon Pharma, Inc. v. Actavis Labs. FL, Inc., 3:15-cv-04916 (D.N.J.);
`
`Pozen, Inc. v. Actavis Laboratories FL, Inc., 17-1615, 17-1616 (Fed. Cir.); Horizon
`
`Pharma, Inc. v. Dr. Reddy’s Labs., Inc., 2:16-cv-04921 (D.N.J.); and Horizon
`
`Pharma, Inc. v. Lupin Ltd., 2:16-cv-04920 (D.N.J.).
`
`Mylan Pharmaceuticals Inc. v. Pozen Inc. and Horizon Pharma USA, Inc.,
`
`IPR2017-01995. Mylan Pharmaceuticals Inc. v. Pozen Inc. and Horizon Pharma
`
`USA, Inc., IPR2018-00272.
`
`U.S. Patent No. 9,393,208 claims, or may claim, the benefit of priority to U.S.
`
`Provisional Application No. 61/095,584 filed on September 9, 2008, the same
`
`application to which the ’698 patent may claim priority. Patent Owner does not
`
`concede that this patent would affect, or be affected by, a decision in the present
`
`inter partes review of the ’698 patent.
`
`
`
`
`
`3
`
`
`
`Case No. IPR2018-00894
`Patent No. 9,220,698
`Patent Owners’ Mandatory Notices
`
`
`LEAD AND BACK-UP COUNSEL 37 C.F.R. § 42.8(b)(3))
`
`Back-up Counsel
`Jonathan G. Graves
`COOLEY LLP
`ATTN: Patent Group
`1299 Pennsylvania Avenue, N.W.,
`Suite 700
`Washington, DC 20004-2400
`Tel: (703) 456-8119
`Fax: (703) 456-8100
`JGraves@cooley.com
`Pro hac vice application to be filed
`Ellen Scordino
`COOLEY LLP
`ATTN: Patent Group
`1299 Pennsylvania Avenue, N.W.,
`Suite 700
`Washington, DC 20004-2400
`Tel: (617) 937-2492
`Fax: (617) 937-2400
`EScordino@cooley.com
`Pro hac vice application to be filed
`
`
`
`Back-up Counsel
`Stephen M. Hash, Ph.D.
`BAKER BOTTS LLP
`98 San Jacinto Blvd.
`Suite 1500
`Austin, TX 78701-4078
`Tel: (512) 322-2587
`Fax: (512) 322-3687
`Stephen.Hash@bakerbotts.com
`USPTO Reg. No. 45,490
`
`4
`
`
`Counsel for Horizon Pharma USA, Inc.:
`
`
`Lead Counsel
`Thomas A. Blinka, Ph.D.
`COOLEY LLP
`ATTN: Patent Group
`1299 Pennsylvania Avenue, N.W.,
`Suite 700
`Washington, DC 20004-2400
`Tel: (202) 842-7800
`Fax: (202) 842-7899
`TBlinka@cooley.com
`USPTO Reg. No. 44,541
`
`
`
`Counsel for Pozen Inc.:
`
`Lead Counsel
`Margaret J. Sampson, Ph.D.
`BAKER BOTTS LLP
`98 San Jacinto Blvd.
`Suite 1500
`Austin, TX 78701-4078
`Tel: (512) 322-2587
`Fax: (512) 322-3687
`Margaret.Sampson@bakerbotts.com
`USPTO Reg. No. 47,052
`
`
`
`
`
`Case No. IPR2018-00894
`Patent No. 9,220,698
`Patent Owners’ Mandatory Notices
`
`
`
`
`Lead Counsel
`
`Back-up Counsel
`Jeffrey S. Gritton
`BAKER BOTTS LLP
`98 San Jacinto Blvd.
`Suite 1500
`Austin, TX 78701-4078
`Tel: (512) 322-2500
`Fax: (512) 322-2501
`Jeff.Gritton@bakerbotts.com
`USPTO Reg. No. 65,314
`SERVICE INFORMATION 37 C.F.R. § 42.8(b)(4))
`Horizon and Pozen hereby consent to electronic service. Please direct all
`
`correspondence to: zIPR2018-00894@cooley.com and pozen-
`
`vimovoBB@bakerbotts.com.
`
`Date: April 26, 2018
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`Respectfully submitted,
`
`By:
`
`
`
`/s/ Thomas A. Blinka
`Thomas A. Blinka
`Reg. No. 44,541
`Counsel for Patent Owner
`
`5
`
`
`
`Case No. IPR2018-00894
`Patent No. 9,220,698
`Patent Owners’ Mandatory Notices
`
`
`CERTIFICATE OF SERVICE UNDER 37 C.F.R. § 42.6(e)
`
`
`
`I, Thomas A. Blinka, hereby certify that on this 26th day of April, 2018, the
`
`foregoing Mandatory Notices was served electronically via email on the following:
`
`Alan H. Pollack (Reg. No. 39,802)
`BUDD LARNER, P.C.
`150 John F. Kennedy Parkway
`Short Hills, New Jersey 07078
`Tel: (973) 379-4800
`apollack@buddlarner.com
`
`Dmitry V. Shelhoff (motion for Pro Hac Vice admission to be filed)
`Stuart D. Sender (Reg. No. 34,248)
`Louis H. Weinstein (Reg. No. 45,205)
`BUDD LARNER, P.C.
`150 John F. Kennedy Parkway
`Short Hills, New Jersey 07078
`Tel: (973) 379-4800
`dshelhoff@buddlarner.com
`ssender@buddlarner.com
`lweinstein@buddlarner.com
`
`Date: April 26, 2018
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`
`6
`
`By:
`/s/ Thomas A. Blinka
` Thomas A. Blinka
`
`Reg. No. 44,541
`
`Counsel for Patent Owner
`
`
`
`
`
`